Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Rethinking high-risk neuroblastoma treatment.
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial.
Control of transposase activity within a transpososome by the configuration of the flanking DNA segment of the transposon.
Relational autonomy: moving beyond the limits of isolated individualism.
False discovery rates: a new deal.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
False discovery rates: a new deal.
False discovery rates: a new deal. Biostatistics. 2017 04 01; 18(2):275-294.
View in:
PubMed
subject areas
Bayes Theorem
Data Interpretation, Statistical
Humans
Models, Statistical
authors with profiles
Matthew Stephens